ARCUATE

Pharmaceutical preparations, namely, preparations for treating metabolic disorders, namely, diabetes and obesity; pharmaceutical preparations for the regulation of food intake; pharmaceutical preparations for the regulation of glucose production; pharmaceutical preparations used to modulate long-chain fatty acyl-CoA levels in the hypothalamus; pharmaceutical preparations used to agonize KATP channels in the hypothalamus; pharmaceutical preparations used to inhibit pyruvate dehydrogenase kinase (PDHK) in the hypothalamus; pharmaceutical preparations used to effect amino acid and other analyte sensing in the hypothalamus for the treatment of obesity and diabetes